Adaptimmune Therapeutics Plc (ADAPY)
0.0525
0.00 (0.00%)
USD |
OTCM |
Dec 09, 16:00
Adaptimmune Therapeutics Shareholders Equity (Quarterly): -70.96M for June 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 34.90M |
| Autolus Therapeutics Plc | 265.45M |
| Mereo BioPharma Group Plc | 46.60M |
| Bicycle Therapeutics Plc | 618.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 130.63M |
| Total Liabilities (Quarterly) | 201.59M |
| Debt to Equity Ratio | -0.686 |
| Current Ratio | 1.516 |
| Net Debt Paydown Yield | -7.87% |